Skip to content

Daniel A. Pryma, MD

NPI 1366417818ActiveIndividual· Nuclear Medicine· Philadelphia, PA

Nuclear Medicine (MD) in Philadelphia, Pennsylvania, licensed in PA, with an NPI issued in February 2006. Medicare paid $62,749 for services to 335 patients in 2024. Novartis Pharmaceuticals Corporation reported $117.26 in payments in 2025, mostly food and beverage.

Overview

NPI1366417818
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedFeb 20, 2006
Last updated in NPPESMay 21, 2012

Specialties and licenses

TaxonomyCodeLicenseState
Nuclear Medicine Primary207U00000XMD427361PA
Specialist174400000XMD427361PA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Nuclear Medicine (NJ); Practitioner - Nuclear Medicine (PA)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients335
Services billed424 across 32 procedure codes
Paid by Medicare$62,749

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$117.26 · 1 payment from 1 company
  • 2024$408.70 · 4 payments from 3 companies

Top paying companies in 2025

CompanyAmountPayments
Novartis Pharmaceuticals Corporation$117.261

What the 2025 payments were for

  • Food and Beverage$117.26 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Nuclear Medicine providers in Philadelphia

All Nuclear Medicine providers in Pennsylvania →